|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED-B
Nominal 
38.750 -0.750 (-1.899%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -13.634% | -3.730% | -14.285% | -117.705% | -15.000% |
| ROAE (%) | -15.899% | -4.283% | -15.844% | -189.237% | N/A |
| Return on Capital Employed (%) | -15.431% | -4.305% | -15.822% | -77.613% | -13.136% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 72.673% | 63.688% | 57.407% | N/A | N/A |
| EBITDA Margin (%) | -676.790% | -1855.769% | -1854925.926% | N/A | N/A |
| Pre-tax Profit Margin (%) | -670.571% | -1933.044% | -1867998.148% | N/A | N/A |
| Net Profit Margin (%) | -670.571% | -1933.107% | -1867998.148% | N/A | N/A |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 8.355 X | 3.924 X | 9.945 X | 24.056 X | 0.260 X |
| Quick Ratio (X) | 8.292 X | 3.911 X | 9.944 X | 24.056 X | 0.260 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 13.929% | 14.517% | 11.343% | 8.507% | 140.295% |
| Total Debt / Total Assets (%) | 8.845% | 7.615% | 7.298% | 5.983% | 1.907% |
| Net Debt / Total Assets (%) | -0.215% | 0.195% | -32.427% | -53.948% | -3.056% |
| Total Debt / Shareholders' Funds (%) | 10.277% | 8.908% | 8.232% | 6.539% | N/A |
| Long Term Debt / Shareholders' Funds (%) | 9.445% | 1.049% | 7.753% | 6.261% | N/A |
| Net Debt / Shareholders' Funds (%) | -0.250% | 0.229% | -36.575% | -58.964% | N/A |
| Net Cash / (Debt) ($) | 12.437M | (12.927M) | 2.155B | 4.034B | 65.302M |
| Net Cash / (Debt) per share ($) | 0.038 | (0.041) | 7.219 | 13.757 | -- |
| Total Debt / Capital Employed (%) | 9.331% | 8.768% | 7.608% | 6.136% | 2.496% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 162.173 Day | 474.775 Day | 7093.696 Day | N/A | -- |
| Receivables Turnover (Day) | 79.810 Day | 75.086 Day | 331.204 Day | N/A | N/A |
| Payables Turnover (Day) | 135.337 Day | 1400.479 Day | 319016.759 Day | N/A | N/A |
| Remarks: | Real time quote last updated: 21/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -632,413,000 |
| %Change | 49.291% |
| EPS / (LPS) | RMB -1.970 |
| NBV Per Share (¥) | RMB 13.567 |